Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to $21.2 million.

  • Fractyl Health's Gains from Investment Securities rose 102459.66% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year increase of 38980.1%. This contributed to the annual value of -$17.9 million for FY2024, which is 30532.26% down from last year.
  • According to the latest figures from Q3 2025, Fractyl Health's Gains from Investment Securities is $21.2 million, which was up 102459.66% from $2.3 million recorded in Q2 2025.
  • Over the past 5 years, Fractyl Health's Gains from Investment Securities peaked at $21.2 million during Q3 2025, and registered a low of -$10.4 million during Q1 2024.
  • In the last 3 years, Fractyl Health's Gains from Investment Securities had a median value of $129000.0 in 2023 and averaged $1.7 million.
  • The largest annual percentage gain for Fractyl Health's Gains from Investment Securities in the last 5 years was 193545.43% (2024), contrasted with its biggest fall of 20902000.0% (2024).
  • Over the past 3 years, Fractyl Health's Gains from Investment Securities (Quarter) stood at $5.6 million in 2023, then crashed by 108.27% to -$466000.0 in 2024, then skyrocketed by 4649.57% to $21.2 million in 2025.
  • Its last three reported values are $21.2 million in Q3 2025, $2.3 million for Q2 2025, and -$825000.0 during Q1 2025.